GoldenGolden
Advanced Search
Periphagen Inc

Periphagen Inc

Periphagen is a biopharmaceutical company founded in 2012 by Darren Wolfe

Periphagen is a biopharmaceutical company founded in 2012 by Darren Wolfe, David Krisky and James Wechuck. It develops herpes simplex virus type I (HSV-1) as a gene therapy vector and focuses on the use of HSV-1 vectors for neurologic disease.

Timeline

April 2014
Periphagen Inc raises a $6,500,000 venture round.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.